BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36035369)

  • 1. Comprehensive Analysis of Transcriptional Expression of hsa-mir-21 Predicted Target Genes and Immune Characteristics in Kidney Renal Clear Cell Carcinoma.
    Xu DM; Li M; Lin SB; Yang ZL; Xu TY; Yang JH; Yin J
    Int J Med Sci; 2022; 19(9):1482-1501. PubMed ID: 36035369
    [No Abstract]   [Full Text] [Related]  

  • 2. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
    Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
    Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of NDUFS1 with CD4
    Wu D; He L; Xu Z; Tian RF; Fan XY; Fan J; Ai J; Bian HJ; Qin WJ; Qin J; Li L
    Front Cell Dev Biol; 2023; 11():1168462. PubMed ID: 37469574
    [No Abstract]   [Full Text] [Related]  

  • 5. The hsa-miR-3613-5p, a potential oncogene correlated with diagnostic and prognostic merits in kidney renal clear cell carcinoma.
    Ahmadi M; Najari-Hanjani P; Ghaffarnia R; Ghaderian SMH; Mousavi P; Ghafouri-Fard S
    Pathol Res Pract; 2023 Nov; 251():154903. PubMed ID: 37879147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
    Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
    Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412
    [No Abstract]   [Full Text] [Related]  

  • 7. A comprehensive analysis of essential meiotic endonuclease 1 to prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Li HD; Ma HX; Ma JH; Kong SP; Zhao ST; Fan SQ; Qin F; Ma JG
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):584-602. PubMed ID: 38305603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. System analysis of
    Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
    Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Zou X; Mo Z
    Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of expression profiles and prognosis of TRIM genes in human kidney clear cell carcinoma.
    Shen J; Wang R; Chen Y; Fang Z; Tang J; Yao J; Gao J; Zhou W; Chen X
    Aging (Albany NY); 2022 May; 14(10):4606-4617. PubMed ID: 35617983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
    Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
    Front Genet; 2022; 13():978840. PubMed ID: 36186442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma.
    Huang M; Zhang T; Yao ZY; Xing C; Wu Q; Liu YW; Xing XL
    BMC Med Genomics; 2021 Mar; 14(1):72. PubMed ID: 33750388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma.
    Yang K; Hu B; Zhu G; Yuan D; Wang W; Su H; Liu H; Zhu J
    Arch Esp Urol; 2023 Jun; 76(4):270-282. PubMed ID: 37455526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma.
    Chalbatani GM; Momeni SA; Mohammadi Hadloo MH; Karimi Z; Hadizadeh M; Jalali SA; Miri SR; Memari F; Hamblin MR
    Comput Biol Med; 2022 Feb; 141():105043. PubMed ID: 34839901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
    Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
    Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
    Liu S; Yu Y; Wang Y; Zhu B; Han B
    Eur J Med Res; 2022 Jul; 27(1):122. PubMed ID: 35842702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
    Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
    Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.